This inventor holds 1 USPTO granted patent. Top assignee: Leland Stanford Junior University. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Christopher Heescheen: Innovator in Therapeutic Angiogenesis
Introduction
Christopher Heescheen is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of therapeutic angiogenesis through his innovative research and patent.
Latest Patents
Heescheen holds a patent titled "Nicotine in Therapeutic Angiogenesis and Vasculogenesis." This invention features methods for the induction of angiogenesis by the administration of nicotine or other nicotine receptor agonists. The methods outlined in this patent can be utilized in therapeutic angiogenesis, particularly in the treatment of ischemic syndromes such as coronary or peripheral arterial disease. Heescheen's work in this area has the potential to impact medical treatments significantly.
Career Highlights
Christopher Heescheen is affiliated with Leland Stanford Junior University, where he continues to advance his research in the medical field. His dedication to innovation and improvement in therapeutic methods is evident in his work.
Collaborations
Heescheen has collaborated with esteemed colleagues, including John P. Cooke and James Jang. These partnerships have further enriched his research and contributed to the development of his patent.
Conclusion
Christopher Heescheen is a pioneering inventor whose work in therapeutic angiogenesis showcases the potential of nicotine in medical treatments. His contributions to the field are noteworthy and reflect his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile